Literature DB >> 9525591

Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells.

A Granelli-Piperno1, E Delgado, V Finkel, W Paxton, R M Steinman.   

Abstract

Dendritic cells (DCs) can develop from CD14+ peripheral blood monocytes cultured in granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin 4 (IL-4). By 6 days in culture, the cells have the characteristics of immature DCs and can be further induced to mature by inflammatory stimuli or by monocyte-conditioned medium. After infection with macrophagetropic (M-tropic) human immunodeficiency virus type 1 (HIV-1), monocytes and mature DCs show a block in reverse transcription and only form early transcripts that can be amplified with primers for the R/U5 region. In contrast, immature DCs cultured for 6 or 11 days in GM-CSF and IL-4 complete reverse transcription and show a strong signal when LTR/gag primers are used. Blood monocytes and mature DCs do not replicate HIV-1, whereas immature DCs can be productively infected, but only with M-tropic HIV-1. The virus produced by immature DCs readily infects activated T cells. Although mature DCs do not produce virus, these cells transmit both M- and T-tropic virus to T cells. In the cocultures, both DCs and T cells must express functional chemokine coreceptors for viral replication to occur. Therefore, the developmental stage of DCs can influence the interaction of these cells with HIV-1 and influence the extent to which M-tropic and T-tropic virus can replicate.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525591      PMCID: PMC109716     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Morphology and phenotype of dendritic cells from peripheral blood and their productive and non-productive infection with human immunodeficiency virus type 1.

Authors:  S Patterson; J Gross; P Bedford; S C Knight
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

3.  Dendritic cell infection, depletion and dysfunction in HIV-infected individuals.

Authors:  S E Macatonia; R Lau; S Patterson; A J Pinching; S C Knight
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

4.  Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells.

Authors:  P U Cameron; P S Freudenthal; J M Barker; S Gezelter; K Inaba; R M Steinman
Journal:  Science       Date:  1992-07-17       Impact factor: 47.728

5.  Adoptive transfer of fluorescence-labeled cells shows that resident peritoneal macrophages are able to migrate into specialized lymphoid organs and inflammatory sites in the mouse.

Authors:  H Rosen; S Gordon
Journal:  Eur J Immunol       Date:  1990-06       Impact factor: 5.532

6.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

Authors:  T Zhu; H Mo; N Wang; D S Nam; Y Cao; R A Koup; D D Ho
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

7.  During HIV-1 infection most blood dendritic cells are not productively infected and can induce allogeneic CD4+ T cells clonal expansion.

Authors:  P U Cameron; U Forsum; H Teppler; A Granelli-Piperno; R M Steinman
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

8.  Early molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cells.

Authors:  E Langhoff; K H Kalland; W A Haseltine
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

9.  HIV-1 selection by epidermal dendritic cells during transmission across human skin.

Authors:  J C Reece; A J Handley; E J Anstee; W A Morrison; S M Crowe; P U Cameron
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone.

Authors:  J M Austyn; J W Kupiec-Weglinski; D F Hankins; P J Morris
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  128 in total

Review 1.  Chemokines and dendritic cell traffic.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

Review 2.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

Review 3.  Dendritic cells: immune saviors or Achilles' heel?

Authors:  C W Cutler; R Jotwani; B Pulendran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Regulation of primary HIV-1 isolate replication in dendritic cells.

Authors:  T H J MacDougall; R J Shattock; C Madsen; B M Chain; D R Katz
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

5.  DC-SIGN interactions with human immunodeficiency virus: virus binding and transfer are dissociable functions.

Authors:  S Pöhlmann; G J Leslie; T G Edwards; T Macfarlan; J D Reeves; K Hiebenthal-Millow; F Kirchhoff; F Baribaud; R W Doms
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages.

Authors:  B Lee; M Sharron; L J Montaner; D Weissman; R W Doms
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

7.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes.

Authors:  Evelyne Schaeffer; Vanessa B Soros; Warner C Greene
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells.

Authors:  Thomas J Ketas; Ines Frank; Per Johan Klasse; Brian M Sullivan; Jason P Gardner; Catherine Spenlehauer; Mirjana Nesin; William C Olson; John P Moore; Melissa Pope
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

Authors:  Louis de Repentigny; Daniel Lewandowski; Paul Jolicoeur
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.